Annual Updates

Hepatitis Annual Update 2008

Modules

• Can Hepatitis B Be Cured?
• Therapy of Chronic Hepatitis B: Who to Treat and When to Treat? A Case-Based Discussion
• Therapy of Chronic Hepatitis B: What to Choose, When to Change, and When to Stop
• New Data on Currently Available HCV Therapies and Their Impact on Initial Treatment Strategies
• Strategies for Management of Hepatitis C Treatment Failure
• HCV Therapy: What Will the Future Look Like?
• Update on Autoimmune Hepatitis: Management Strategies
• Managing the Complications of Cirrhosis
• Hepatitis Journal Club: Top Clinical Articles of 2007-08

Hepatitis Annual Update 2007

Modules

• Epidemiology and Natural History of HBV Infection
• HBV: 2007 Treatment Overview
• A Practical Guide to Management of Patients With Antiviral Drug-Resistant HBV
• Treatment of Hepatitis B Virus Infection in Special Populations
• Molecular Virology of the Hepatitis C Virus: Implication for Novel Therapies
• Update on New Hepatitis C Virus Therapies
• Tailoring Treatment for Hepatitis C: Strategies to Overcome Nonresponse
• Insulin Resistance and Hepatic Steatosis in Patients With Chronic Hepatitis C
• Growing Pains: Obesity, Bariatric Surgery, and Nonalcoholic Fatty Liver Disease
• The Epidemic of Hepatocellular Carcinoma: Diagnosis and Therapy
• Best of Hepatitis 2007: Top Findings in Viral Hepatitis

Hepatitis Annual Update 2006

Modules

• Hepatitis B Virus Resistance for Clinicians
• The Changing Face of Antiviral Therapy in Hepatitis B
• New Agents in Development for Hepatitis B
• Update on the Management of HBV
• Interferon and Ribavirin: Mechanisms of Action, Resistance, and Why It Matters
• New Therapies for Chronic Hepatitis C
• Customizing HCV Therapy With Current Agents: Optimizing Patient Outcomes
• Debate: Are Noninvasive Tests Ready to Replace Liver Biopsy?
• Liver Transplantation: The Past Quarter Century and the Future
• The Paradox of Treating Liver Disease With Potentially Hepatotoxic Drugs

Animations

• Life Cycle of Hepatitis C Virus
• Drug Targets in the Hepatitis C Virus Life Cycle

CCO Slidesets

• 4th Annual Clinical Care Options for Hepatitis Symposium: HBV Highlights
• 4th Annual Clinical Care Options for Hepatitis Symposium: HCV Highlights
• 4th Annual Clinical Care Options for Hepatitis Symposium: Hot Topics

Hepatitis Annual Update 2005

Modules

• Understanding Mechanisms of Drug Action and Viral Resistance in HBV
• HBV: Why Do You Treat, Whom Do You Treat, What Are the Endpoints?
• New Data on Hepatitis B Virus Treatment
• Point/Counterpoint: Interferon or Nucleoside/Nucleotide Analogues as First-Line Therapy for Hepatitis B?
• Molecular Basis of HCV Therapy
• Hepatitis C Treatment: 2005
• Treatment for Hepatitis C Nonresponders and Relapsers
• Managing Side Effects of HCV Therapy
• Current Assessment of Fibrosis
• Nonalcoholic Fatty Liver Disease
• Advances in Hepatology: 2005

Animation

• Life Cycle of Hepatitis B Virus

Hepatitis Annual Update 2004

Modules

• Immunopathogenesis of Acute Hepatitis B and Hepatitis C
• HBV Treatment Guidelines: Questions and Controversies
• New Data on Hepatitis B Virus Treatment
• Natural History, Diagnostics, and Clinical Profiles of Persons With Chronic Hepatitis B
• World Epidemiology of Hepatitis C
• Hepatitis C Treatment: Today and Tomorrow
• Impact of Nonalcoholic Fatty Liver Disease on Hepatitis C
• Cirrhosis and Beyond
• Hepatocellular Carcinoma
• HIV Coinfection
• Drug Induced Hepatotoxicity: 2004

Hepatitis Annual Update 2003

Modules

• Natural History of Hepatitis C
• Immunopathogenesis of Fibrosis and Relevance to Therapeutic Targets
• Treatment of Hepatitis C: The State of the Art
• Re-Treatment of Hepatitis C in Nonresponders/Relapsers
• HCV/HIV Coinfection
• Managing Psychiatric Side Effects of Interferon
• Managing the Hematologic Complications of Interferon/Ribavirin
• HCV Life Cycle and Targets for Drug Development
• Novel Therapies and Therapeutic Strategies for HCV
• Treatment of Hepatitis B: The State of the Art
• Novel Therapies and Therapeutic Strategies for HBV
• The Identification of HCV and Eradication of Posttransfusion Hepatitis

Animations

• Sinusoidal Changes in Liver Fibrogenesis